Rohidas M. Jagtap¹, Sachin S. Sakate¹, Satish K. Pardeshi² and Masood A. Rizvi³
¹Department of Chemistry, P. E. S. Modern College of Arts, Science and Commerce (Autonomous), Shivajinagar, Pune, MS, India
²Department of Chemistry, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, MS, India
³Department of Chemistry, University of Kashmir, Hazratbal, Srinagar, Jammu and Kashmir, India

Part of the book: Advances in Chemistry Research. Volume 76

Chapter DOI: https://doi.org/10.52305/KSNB2027

Abstract

The X-ray crystallography is credibly an unequivocal state of art tool for authentication of the stereochemistry of chiral bioactive organic compounds. The acquired diffraction data processed to deliver the exact stereostructure of the compound which can be further correlated to the biological activity of that compound. The 2-alkyl/aryl thiazolidine-4- carboxylic acids (2A-T4CA) and their derivatives have sufficient H-bonding sites which enables the researcher to crystallize them to an absolute purity for diffraction by single crystal X-ray spectroscopy. In this regard, the thiazolidine class of organosulfur compounds and some of their organometallic complexes have been explored by the researchers for their single crystal X-ray structures. Apart from the cardiovascular diseases, cancer stands second in human mortality. The discovery and development of small molecular drugs (SMD) for cancer treatment is always desired as they are more effective in genetic additions, dependencies and vulnerabilities of cancer cells. Considering the SMD application of T4CA and their derivatives, these thioazolidines are widely investigated by various research groups for their in vitro anticancer activities against several human cancer cell lines. The present chapter give emphasis on the single crystal X-ray structures and anticancer properties of the T4CA as significant thiazolidine class moieties.

References

[1] Parthasarathy, R., Paul, B. and Korytnykic, W. (1976). X-Ray and NMR Studies on
Thiazolidines: Crystal Structure and Conformational Equilibria of N-Acetyl-2-(p tolyl)thiazolidine-4-carboxylic Acid and Related Thiazolidine Derivatives, Journal of American Chemical Society, 98, 6634-6641.
[2] Robert, F. (1976). The Crystal and Molecular Structure of N-t-Butyloxycarbonyl L-thiazolidine-4-carboxylic Acid (C9H15NO4S), Acta Crystallographica, B32, 2367-2369.
[3] Howard-Lock, H. E., Lyne-Lock, C. J., Smalley, P. S. (1985). (S)-2,2,5,5-
Tetramethylthiazolidine-4-carboxylic acid: a compound which exists in the amino
acid rather than the zwitter ion form, Canadian Journal of Chemistry, 63, 2411-2419.
[4] Tarnawski, M., Lepokura, K. S. and Lis, T. (2011). Crystal structures of (2R,4R)-2-
(polyhydroxyalkyl)-1,3-thiazolidine-4-carboxylic acids: condensation products of
L-cysteine with D-hexoses, Carbohydrate Research, 346,127-132.
[5] Lewis, W. and Steel, P. J. (2010). Chiral heterocyclic ligands. XVI: Synthesis and
crystal structures of four metal complexes of a tridentate, biheterocyclic ligand
derived from L-cysteine, Polyhedron, 29, 2220-2224.
[6] Song, Z. C., Mab, G. Y. and Zhu, H. L. (2015). Synthesis, characterization and
antibacterial activities of N-tert-butoxycarbonyl-thiazolidine carboxylic acid, RSC
Advances, 5, 24824-24833.
[7] Muche, S., Muller, M. and Hołynska, M. (2018). Synthesis, characterization and
crystal structure of (2RS,4R)-2-(2-hydroxy-3-methoxyphenyl)thiazolidine-4-
carboxylic acid, Journal of Molecular Structure, 1155, 65-71.
[8] Jagtap, R. M., Rizvi, M. A., Dangat, Y. B. and Pardeshi, S. K. (2016). Crystal
structure, computational studies, and stereoselectivity in the synthesis of 2-aryl
thiazolidine-4-carboxylic acids via in situ imine intermediate, Journal of Sulfur
Chemistry, 37, 4, 401-425.
[9] Song, Z. C., Mab, G. Y. and Zhu, H. L. (2015). Synthesis, characterization and
antibacterial activities of N-tert-butoxycarbonyl-thiazolidine carboxylic acid, RSC
Advances, 5, 24824-24833.
[10] Hoelder, S., Clarke, P. A. and Workman, P. (2012). Discovery of small molecule
cancer drugs: Successes, challenges and opportunities, Molecular Oncology, 6,
155-176.
[11] Gududuru, V., Hurh, E., Dalton, J. T. and Miller, D. D. (2005). Discovery of 2-
Arylthiazolidine-4-carboxylic Acid Amides as a New Class of Cytotoxic Agents for
Prostate Cancer, Journal of Medicinal Chemistry, 48, 2584-2588.
[12] Chen, J., Wang, Z., Lu, Y., Dalton, J. T., Miller, D. D. and Li, W. (2008). Synthesis
and antiproliferative activity of imidazole and imidazoline analogs for melanoma,
Bioorganic and Medicinal Chemistry Letters, 18, 3183-3187.
[13] Corbi, P. P., Andrade, F. C., Massabni, A. C., Heinrich, T. A., Souza, P. P. C. and
Costa-Neto, C. M. (2008). Lithium thiazolidine-4-carboxylate: Synthesis,
spectroscopic characterization and preliminary in vitro cytotoxic studies in human
HeLa cells, Spectrochimica Acta, Part A, 71, 929-931.
[14] Lu, Y., Li, C. M., Wang, Z., Ross, C. R., Chen, J., Dalton, J. T., Li, W. and Miller,
D. D. (2009). Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel
Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity
Relationships, Journal of Medicinal Chemistry, 52, 1701-1711.
[15] Lu, Y., Wanga, Z., Li, C. M., Chen, J., Dalton, J. T., Li, W. and Miller, D. D. (2010).
Synthesis, in vitro structure–activity relationship, and in vivo studies of 2-
arylthiazolidine-4-carboxylic acid amides as anticancer agents, Bioorganic and
Medicinal Chemistry Letters, 18, 477-495.
[16] Thalamuthu, S., Annaraj, B., Vasudevan, S., Sengupta, S. and Neelakantan, M. A.
(2013). DNA binding, nuclease, and colon cancer cell inhibitory activity of a Cu
(II) complex of a thiazolidine-4-carboxylic acid derivative, Journal of Coordination
Chemistry, 66, 1805-1820.
[17] Onen-Bayram, F. E., Durmaz, I., Scherman, D., Herscovici, J. and Cetin-Atalay, R.
(2012). A novel thiazolidine compound induces caspase-9 dependent apoptosis in
cancer cells, Bioorganic and Medicinal Chemistry, 20, 5094-5102.
[18] Onen-Bayram, F. E., Buran, K., Durmaz, I., Berkc, B. and Cetin-Atalay, R. (2015).
3-Propionyl-thiazolidine-4-carboxylic acid ethyl esters: a family of antiproliferative
thiazolidines, Medicinal Chemistry Communications, 6, 90-93.
[19] Serra, A. C., d’A. A. M., Gonsalves, R., Laranjo, M., Abrantes, A. M., Goncalves,
A. C., Sarmento-Ribeiro, A. B. and Botelho, M. F. (2012). Synthesis of new 2-
galactosylthiazolidine-4-carboxylic acid amides: Antitumor evaluation against
melanoma and breast cancer cells, European Journal of Medicinal Chemistry, 53,
398-402.
[20] Bertamino, A., Soprano, M., Musella, S., Rusciano, M. R., Sala, M., Vernieri, E.,
Sarno, V. D., Limatola, A., Carotenuto, A., Cosconati, S., Grieco, P., Novellino, E.,
Illario, M., Campiglia, P. and Gomez-Monterrey, I. (2013). Synthesis, in Vitro, and
in Cell Studies of a New Series of [Indoline-3,2′-thiazolidine]-Based p53
Modulators, Journal of Medicinal Chemistry, 56, 5407-5421.
[21] Soares, M. I. L., Brito, A. F., Laranjo, M., Paixao, J. A., Botelho, M. F. and Pinho
e Melo, T. M. V. D. (2013). Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-
c]thiazoles with anti-breast cancer properties, European Journal of Medicinal
Chemistry, 60, 254-262.
[22] Jagtap, R. M., Thorat, S. H., Gonnade, R. G., Khan, A. A. and Pardeshi, S. K.
(2017). X-ray crystal structures and anti-breast cancer property of 3-tert-
butoxycarbonyl-2-arylthiazolidine-4-carboxylic acids, New Journal of Chemistry,
42, 2, 1078-1086
[23] Chen, J. S. K., Konopleva, M., Andreeff, M., Multani, A. Pathak, S. and Mehta K.
(2004). Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive
to apoptosis, Journal of Cell Physiology, 200, 223-234.
[24] Pellegrini, N. Refouvelet, B. Crini, G., Blacque, O., Kubicki, M. M. and Robert, J.
F. (1999). New Dipeptides Containing Thiazolidine-4-carboxylic Acid Derivatives:
Synthesis and Characterization Using NMR Techniques and X-Ray Data, Chemical
and Pharmaceutical Bulletin, 47, 950-955.
[25] Hayashi, Y., Kinoshita, Y., Hidaka, K., Kiso, A., Uchibori, H., Kimura, T. and Kiso,
Y. (2001). Analysis of Amide Bond Formation with an α-Hydroxy-β-amino Acid
Derivative, 3-Amino-2-hydroxy-4-phenylbutanoic Acid, as an Acyl Component:
Byproduction of Homobislactone, Journal of Organic Chemistry, 66, 5537-5544.
[26] Li, W., Lu, Y., Wang, Z., Dalton, J. T. and Miller, D. D. (2007). Synthesis and
antiproliferative activity of thiazolidine analogs for melanoma, Bioorganic and
Medicinal Chemistry Letters, 17, 4113-4117.
[27] Chen, J., Wang, Z., Lu, Y., Dalton, J. T., Miller, D. D. and Li, W. (2008). Synthesis
and antiproliferative activity of imidazole and imidazoline analogs for melanoma,
Bioorganic and Medicinal Chemistry Letters, 18, 3183-3187.
[28] Solomon, V. R., Haq, W., Srivastava, K., Puri, S. K. and Katti, S. B. (2013). Design,
Synthesis of 4-aminoquinoline-derived thiazolidines and their antimalarial activity
and heme polymerization inhibition studies, Journal of Enzyme Inhibition and
Medicinal Chemistry, 28, 619-626.
[29] Garza, I., Wallace, M. J., Fernando, D., Singh, A., Lee, R. E., Gerding, J. S.,
Franklin, C. and Yendapally, R. (2017). Synthesis and Evaluation of Thiazolidine
Amide and N-Thiazolyl Amide Fluoroquinolone Derivatives, Archiv der
Pharmazie – Chemistry in Life Sciences, 350, 170002-170011.
[30] Jagtap, R. M., Shaikh, S. R., Gonnade, R. G., Raheem, S., Rizvi, M. A., Pardeshi,
S. K. (2019). Cyanuric‐Chloride‐Mediated Synthesis of 2‐Aryl‐3‐tert‐
butoxycarbonyl‐thiazolidine‐4‐carboxylic Acid Anilides: Mechanistic, X‐Ray
Crystal Structures and Cytotoxicity Studies, ChemistrySelect, 4, 43, 12534-12546.
[31] Rizvi, M. A., Guru, S., Naqvi, T., Kumar, M., Kumbhar, N., Akhoon, S., Banday,
S., Singh, S. K., Bhushan, S., Peerzada, G. M. and Shah, B. A. (2014). An
investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides,
Bioorganic and Medicinal Chemistry Letters, 24, 3440-3446.